Katsuhiro Iba

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Fumihiko Sakai, Norihiro Suzuki, Byung‐Kun Kim et al. · Headache The Journal of Head and Face Pain · 2021 · 107 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10

Efficacy and safety of fremanezumab for chronic migraine prevention: Multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group trial in Japanese and Korean patients

Fumihiko Sakai, Norihiro Suzuki, Byung‐Kun Kim et al. · Headache The Journal of Head and Face Pain · 2021 · 98 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +14

Re-evaluation of the comparative effectiveness of bootstrap-based optimism correction methods in the development of multivariable clinical prediction models

Katsuhiro Iba, Tomohiro Shinozaki, Kazushi Maruo et al. · Terrestrial Environment Research Center (University of Tsukuba) · 2021 · 65 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +14

Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study

Yu Nakamura, Jun Adachi, Naoki Hirota et al. · Alzheimer s & Dementia · 2024 · 28 citations · Full text

Medicine, Pharmacology, Psychiatry +13

Long-Term Safety and Tolerability of Fremanezumab for Migraine Preventive Treatment in Japanese Outpatients: A Multicenter, Randomized, Open-Label Study

Fumihiko Sakai, Norihiro Suzuki, Xiaoping Ning et al. · Drug Safety · 2021 · 18 citations · Full text

Pharmacy, Pharmacotherapy, Preventive Medicine +15